Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Protalix Biotherapeutics Inc V.PLX.H


Primary Symbol: PLX

Protalix BioTherapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of recombinant therapeutic proteins expressed through its proprietary plant cell-based expression system, ProCellEx. In addition, the Company is developing PEGylated uricase, or PRX-115, for the treatment of severe gout, Long Acting (LA) DNase I, or PRX-119, for the treatment of NETs-related diseases, and other technologies and preclinical assets. Its product, Elelyso is an enzyme replacement therapy (ERT) for the treatment of patients with Gaucher disease. Its ProCellEx platform is being used to manufacture both of its approved and marketed products as well as PRX-115 and PRX-119. PRX-115, a plant cell-expressed recombinant PEGylated Uricase (urate oxidase)- a chemically modified enzyme under development for the potential treatment of severe gout. PRX-119 is a plant cell-expressed PEGylated recombinant human DNase I product candidate.


NYSEAM:PLX - Post by User

Comment by mike49on Feb 20, 2019 5:34pm
55 Views
Post# 29390719

RE:RE:RE:RE:FYI....

RE:RE:RE:RE:FYI....I remember him from arsenal energy and arcan.
Imo, if he is getting involved, he thinks there is some kind of deal/acquisition in the works.
Go to stockwatch and type his name in the keyword search- go back as many years as you want.
Looks like he was buying again today
Here's a little about him from few years back...

 

Robert Jackson's Vaaldiam Mining Inc. (VAA) fell one-half cent to 25 cents on 985,000 shares. Bruce Mitchell, a Nepean-based former manager of the Canadian Broadcasting Corporation pension fund and a major Vaaldiam shareholder, significantly increased his holdings last week. Mr. Mitchell's latest Vaaldiam purchase comes on the heels of an unexpected friendly takeover bid from Cayman Islands-based BCKP Ltd., which is offering 25.8 cents per share. (He bought 2.2 million shares at 24.7 cents per share and now holds 8.7 million shares, just over 12 per cent of the company's stock.) Mr. Mitchell, considered one of the most active stock traders through the 1980s and 1990s, has been a busy investor on his own since then, accumulating considerable positions in several junior resource companies. In fact, so busy was Mr. Mitchell with his investing that he apparently fell behind on his paperwork. Late last year the Ontario Securities Commission cited him for not filing insider trading reports covering substantial investments in several companies between 2006 and 2008. Mr. Mitchell settled the affair early this year, agreeing to pay $70,000 in fines and costs.
stay safe

<< Previous
Bullboard Posts
Next >>